ArticleCureus2026

Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report.

Takayuki Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.